CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05404 | BRD-K09552525 | BRD-K09552525 | -- | -- | -- | Details |
| C05405 | BRD-K09553491 | BRD-K09553491 | -- | -- | -- | Details |
| C05406 | BRD-K09555199 | BRD-K09555199 | -- | -- | -- | Details |
| C05407 | BRD-K09557221 | SR-147778 | CNR1 | Cannabinoid receptor antagonist | -- | Details |
| C05408 | BRD-K09557852 | BRD-K09557852 | -- | -- | -- | Details |
| C05409 | BRD-K09560946 | BRD-K09560946 | -- | -- | -- | Details |
| C05410 | BRD-K09563163 | BRD-K09563163 | -- | -- | -- | Details |
| C05411 | BRD-K09583061 | BRD-K09583061 | -- | -- | -- | Details |
| C05412 | BRD-K09584219 | BRD-K09584219 | -- | -- | -- | Details |
| C05413 | BRD-K09584843 | BRD-K09584843 | -- | -- | -- | Details |
| C05414 | BRD-K09587429 | BRD-K09587429 | -- | -- | -- | Details |
| C05415 | BRD-K09594570 | BRD-K09594570 | -- | -- | -- | Details |
| C05416 | BRD-K09596790 | BRD-K09596790 | -- | -- | -- | Details |
| C05417 | BRD-K09597441 | STAT-5-INHIBITOR | -- | -- | -- | Details |
| C05418 | BRD-K09597785 | BRD-K09597785 | -- | -- | -- | Details |
| C05419 | BRD-K09598619 | BRD-K09598619 | -- | -- | -- | Details |
| C05420 | BRD-K09602097 | forskolin | ADCY2 | Adenylyl cyclase activator | -- | Details |
| C05421 | BRD-K09607752 | BRD-K09607752 | -- | -- | -- | Details |
| C05422 | BRD-K09613355 | BRD-K09613355 | -- | -- | -- | Details |
| C05423 | BRD-K09615275 | BRD-K09615275 | -- | -- | -- | Details |
| C05424 | BRD-K09619322 | CD-1530 | RARG | Retinoid receptor agonist | -- | Details |
| C05425 | BRD-K09620519 | BRD-K09620519 | -- | -- | -- | Details |
| C05426 | BRD-K09623383 | BRD-K09623383 | -- | -- | -- | Details |
| C05427 | BRD-K09631521 | thiotepa | CYP2B6; CYP3A4 | Cytochrome P450 inhibitor | -- | Details |
| C05428 | BRD-K09632545 | BRD-K09632545 | -- | -- | -- | Details |
| C05429 | BRD-K09635134 | BRD-K09635134 | -- | -- | L-erythro-MAPP | Details |
| C05430 | BRD-K09635314 | m-3M3FBS | PLCB2; PLCB3; PLCD1; PLCG1; PLCG2 | Phospholipase activator | M-3M3FBS | Details |
| C05431 | BRD-K09638361 | IC-261 | CSNK1E | Casein kinase inhibitor | SA-63133 | Details |
| C05432 | BRD-K09640010 | BRD-K09640010 | -- | -- | -- | Details |
| C05433 | BRD-K09641113 | BRD-K09641113 | -- | -- | -- | Details |
| C05434 | BRD-K09641927 | BRD-K09641927 | -- | -- | -- | Details |
| C05435 | BRD-K09645804 | BRD-K09645804 | -- | -- | -- | Details |
| C05436 | BRD-K09651570 | BRD-K09651570 | -- | -- | -- | Details |
| C05437 | BRD-K09655230 | BRD-K09655230 | -- | -- | -- | Details |
| C05438 | BRD-K09661167 | BRD-K09661167 | -- | -- | -- | Details |
| C05439 | BRD-K09663164 | BRD-K09663164 | -- | -- | -- | Details |
| C05440 | BRD-K09668667 | BRD-K09668667 | -- | -- | benzo(a)pyrene | Details |
| C05441 | BRD-K09689420 | BRD-K09689420 | -- | -- | -- | Details |
| C05442 | BRD-K09693670 | BRD-K09693670 | -- | -- | -- | Details |
| C05443 | BRD-K09699976 | BRD-K09699976 | -- | -- | -- | Details |
| C05444 | BRD-K09700964 | BRD-K09700964 | -- | -- | -- | Details |
| C05445 | BRD-K09701578 | BRD-K09701578 | -- | -- | -- | Details |
| C05446 | BRD-K09703570 | BRD-K09703570 | -- | -- | -- | Details |
| C05447 | BRD-K09708845 | BRD-K09708845 | -- | -- | -- | Details |
| C05448 | BRD-K09711437 | varespladib | PLA2G2A | Secretory phospholipase inhibitor | -- | Details |
| C05449 | BRD-K09711841 | BRD-K09711841 | -- | -- | -- | Details |
| C05450 | BRD-K09716788 | BRD-K09716788 | -- | -- | -- | Details |
| C05451 | BRD-K09720842 | BRD-K09720842 | -- | -- | -- | Details |
| C05452 | BRD-K09721123 | BRD-K09721123 | -- | -- | -- | Details |
| C05453 | BRD-K09721398 | BRD-K09721398 | -- | -- | -- | Details |
| C05454 | BRD-K09721867 | BRD-K09721867 | -- | -- | -- | Details |
| C05455 | BRD-K09722997 | BRD-K09722997 | -- | -- | -- | Details |
| C05456 | BRD-K09725203 | BRD-K09725203 | -- | -- | -- | Details |
| C05457 | BRD-K09729851 | BRD-K09729851 | -- | -- | -- | Details |
| C05458 | BRD-K09732051 | BRD-K09732051 | -- | -- | -- | Details |
| C05459 | BRD-K09749233 | BRD-K09749233 | -- | -- | -- | Details |
| C05460 | BRD-K09757388 | atazanavir | -- | -- | -- | Details |
| C05461 | BRD-K09757845 | BRD-K09757845 | -- | -- | -- | Details |
| C05462 | BRD-K09761560 | BRD-K09761560 | -- | -- | -- | Details |
| C05463 | BRD-K09764130 | mead-ethanolamide | -- | -- | -- | Details |
| C05464 | BRD-K09767179 | allantoxanamide | -- | -- | -- | Details |
| C05465 | BRD-K09767767 | BRD-K09767767 | -- | -- | -- | Details |
| C05466 | BRD-K09777330 | BRD-K09777330 | -- | -- | -- | Details |
| C05467 | BRD-K09778810 | FGIN-1-27 | TSPO | IMPase inhibitor | -- | Details |
| C05468 | BRD-K09779552 | BRD-K09779552 | -- | -- | -- | Details |
| C05469 | BRD-K09779858 | BRD-K09779858 | -- | -- | -- | Details |
| C05470 | BRD-K09780243 | BRD-K09780243 | -- | -- | -- | Details |
| C05471 | BRD-K09784055 | BRD-K09784055 | -- | -- | benzo(e)pyrene | Details |
| C05472 | BRD-K09787095 | BRD-K09787095 | -- | -- | -- | Details |
| C05473 | BRD-K09790412 | H-9 | PRKACA | PKA inhibitor | -- | Details |
| C05474 | BRD-K09796338 | BRD-K09796338 | -- | -- | -- | Details |
| C05475 | BRD-K09796735 | BRD-K09796735 | -- | -- | -- | Details |
| C05476 | BRD-K09804899 | BRD-K09804899 | -- | -- | -- | Details |
| C05477 | BRD-K09817289 | BRD-K09817289 | -- | -- | -- | Details |
| C05478 | BRD-K09819684 | BRD-K09819684 | -- | -- | -- | Details |
| C05479 | BRD-K09821361 | deferoxamine-mesylate | -- | -- | -- | Details |
| C05480 | BRD-K09821933 | BRD-K09821933 | -- | -- | -- | Details |
| C05481 | BRD-K09824708 | BRD-K09824708 | -- | -- | -- | Details |
| C05482 | BRD-K09840196 | phthalic-anhydride | -- | -- | -- | Details |
| C05483 | BRD-K09842906 | BRD-K09842906 | -- | -- | -- | Details |
| C05484 | BRD-K09845511 | BRD-K09845511 | -- | -- | -- | Details |
| C05485 | BRD-K09845534 | BRD-K09845534 | -- | -- | -- | Details |
| C05486 | BRD-K09852122 | BRD-K09852122 | -- | -- | -- | Details |
| C05487 | BRD-K09854848 | MD-II-008-P | -- | -- | -- | Details |
| C05488 | BRD-K09859624 | methantheline | -- | -- | -- | Details |
| C05489 | BRD-K09861842 | BRD-K09861842 | -- | -- | -- | Details |
| C05490 | BRD-K09863466 | BRD-K09863466 | -- | -- | -- | Details |
| C05491 | BRD-K09864793 | BRD-K09864793 | -- | -- | -- | Details |
| C05492 | BRD-K09871160 | BRD-K09871160 | -- | -- | -- | Details |
| C05493 | BRD-K09875820 | BRD-K09875820 | -- | -- | -- | Details |
| C05494 | BRD-K09876067 | BRD-K09876067 | -- | -- | -- | Details |
| C05495 | BRD-K09877029 | VS-4718 | -- | -- | -- | Details |
| C05496 | BRD-K09878843 | BRD-K09878843 | -- | -- | -- | Details |
| C05497 | BRD-K09879686 | BRD-K09879686 | -- | -- | -- | Details |
| C05498 | BRD-K09880340 | BRD-K09880340 | -- | -- | -- | Details |
| C05499 | BRD-K09887211 | BRD-K09887211 | -- | -- | -- | Details |
| C05500 | BRD-K09895564 | BRD-K09895564 | -- | -- | -- | Details |
| C05501 | BRD-K09900382 | BRD-K09900382 | -- | -- | -- | Details |
| C05502 | BRD-K09900591 | caffeic-acid | ALOX5 | Lipoxygenase inhibitor; NFKB pathway inhibitor; HIV integrase inhibitor; PPAR receptor modulator; TNF production inhibitor; Nitric oxide production inhibitor; Tumor necrosis factor production inhibitor | -- | Details |
| C05503 | BRD-K09902564 | BRD-K09902564 | -- | -- | -- | Details |